Ann: US Dept of Defence & access to other Federal contracts, page-57

Got to say, I am fully hoping for a pull back and would be happy to get some more sub $1.
But seriously, I doubt I'll get the opportunity now. With CE approval, UK sales, breast implant development announcements and further sales milestones all likely in the next 6 months there will be plenty to keep nomentum going. I wouldn't be at all surprised to see it over $1.20 when CE approval is announced.

Honestly I never thought it would go up this fast, and until the recent announcements I thought it was pretty expensive. But with $1m in sales for April already, Aus & NZ markets going well with government rebates to patients, now Medicare and Medicaid in the US have stepped up with patient reimbursements, European distributor ready to go with hundreds of clients... surely its pure gold. The thing that really sticks in my mind was the frequency of early re-ordering from hospitals that have used it. Even the company was surprised. That tells you how well it works, how useful it is, and how much surgeons love it.

I don't know for sure why it works so much better than other products. But the fact that it does is enough.